Bomba-Opon Dorota, Wielgos Miroslaw, Szymanska Monika, Bablok Leszek
1st Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland.
Neuro Endocrinol Lett. 2006 Feb-Apr;27(1-2):277-80.
The investigation of the influence of maternal serum free fatty acids (FFA) levels on the course of gestational diabetes mellitus (GDM).
On the basis of GDM diagnosis 52 diabetic and 39 non-diabetic pregnant women were recruited to the study. Treatment modalities for diabetic group included diet alone (GDM1; n-36) or a combination of insulin and diet (GDM2; n-16). Maternal serum free fatty acids were measured before treatment, after 4 weeks therapy, during delivery and in umbilical cord blood.
Plasma levels of FFA were higher in GDM pregnant women treated later only by diet compare with GDM patients required later insulin and non-diabetic gravidas. In GDM diet treated group plasma FFA levels progressively decreased with treatment duration. The plasma FFA levels in umbilical cord blood did not differ between the study groups. We found a positive correlation between maternal venous and umbilical cord blood concentration of free fatty acids. Maternal FFA levels positively correlated with neonatal births weight.
Elevated plasma FFA levels are associated with GDM and can influence fetal growth. Early and intensified GDM treatment may decrease the level of circulating fatty acids.
探讨母体血清游离脂肪酸(FFA)水平对妊娠期糖尿病(GDM)病程的影响。
基于GDM诊断,招募了52例糖尿病孕妇和39例非糖尿病孕妇参与研究。糖尿病组的治疗方式包括单纯饮食治疗(GDM1组;n = 36)或胰岛素与饮食联合治疗(GDM2组;n = 16)。在治疗前、治疗4周后、分娩时及脐血中检测母体血清游离脂肪酸。
仅采用饮食治疗的GDM孕妇血浆FFA水平高于后期需要胰岛素治疗的GDM患者及非糖尿病孕妇。在GDM饮食治疗组中,血浆FFA水平随治疗时间逐渐降低。研究组间脐血中的血浆FFA水平无差异。我们发现母体静脉血和脐血中游离脂肪酸浓度呈正相关。母体FFA水平与新生儿出生体重呈正相关。
血浆FFA水平升高与GDM相关,且可影响胎儿生长。早期强化GDM治疗可能会降低循环脂肪酸水平。